Strain identifier
BacDive ID: 1743
Type strain:
Species: Bifidobacterium longum subsp. infantis
Strain Designation: S12
Strain history: CIP <- 1964, Lab. Ident., Inst. Pasteur, Paris, France, Bifidobacterium infantis, biotype V <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain S12
NCBI tax ID(s): 391904 (strain), 1682 (subspecies)
General
@ref: 8514
BacDive-ID: 1743
DSM-Number: 20088
keywords: genome sequence, 16S sequence, Bacteria, anaerobe, mesophilic
description: Bifidobacterium longum subsp. infantis S12 is an anaerobe, mesophilic bacterium that was isolated from intestine of infant.
NCBI tax id
NCBI tax id | Matching level |
---|---|
391904 | strain |
1682 | subspecies |
strain history
@ref | history |
---|---|
8514 | <- G. Reuter, S12 |
67770 | ATCC 15697 <-- G. Reuter S12. |
120651 | CIP <- 1964, Lab. Ident., Inst. Pasteur, Paris, France, Bifidobacterium infantis, biotype V <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain S12 |
doi: 10.13145/bacdive1743.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/actinomycetota
- domain: Bacteria
- phylum: Actinomycetota
- class: Actinomycetes
- order: Bifidobacteriales
- family: Bifidobacteriaceae
- genus: Bifidobacterium
- species: Bifidobacterium longum subsp. infantis
- full scientific name: Bifidobacterium longum subsp. infantis (Reuter 1963) Mattarelli et al. 2008
synonyms
- @ref: 20215
- synonym: Bifidobacterium infantis
@ref: 8514
domain: Bacteria
phylum: Actinobacteria
class: Actinobacteria
order: Bifidobacteriales
family: Bifidobacteriaceae
genus: Bifidobacterium
species: Bifidobacterium longum subsp. infantis
full scientific name: Bifidobacterium longum subsp. infantis (Reuter 1963) Mattarelli et al. 2008
strain designation: S12
type strain: yes
Morphology
cell morphology
@ref | motility | confidence | gram stain | cell shape |
---|---|---|---|---|
69480 | no | 93.332 | ||
69480 | 100 | positive | ||
120651 | no | positive | rod-shaped |
colony morphology
- @ref: 120651
Culture and growth conditions
culture medium
@ref | name | growth | link | composition |
---|---|---|---|---|
8514 | BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) | yes | https://mediadive.dsmz.de/medium/58 | Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water |
37702 | MEDIUM 20 - for Anaerobic bacteria | yes | Agar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml) | |
120651 | CIP Medium 20 | yes | https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20 |
culture temp
@ref | growth | type | temperature | range |
---|---|---|---|---|
8514 | positive | growth | 37 | mesophilic |
37702 | positive | growth | 37 | mesophilic |
67770 | positive | growth | 37 | mesophilic |
Physiology and metabolism
oxygen tolerance
@ref | oxygen tolerance | confidence |
---|---|---|
8514 | anaerobe | |
69480 | anaerobe | 98.787 |
spore formation
@ref | spore formation | confidence |
---|---|---|
69481 | no | 99 |
69480 | no | 99.976 |
murein
- @ref: 8514
- murein short key: A21.03
- type: A3ß L-Orn-L-Ser-L-Ala-L-Thr-L-Ala
metabolite utilization
@ref | metabolite | utilization activity | kind of utilization tested | Chebi-ID |
---|---|---|---|---|
68371 | Potassium 5-ketogluconate | - | builds acid from | |
68371 | Potassium 2-ketogluconate | - | builds acid from | |
68371 | gluconate | - | builds acid from | 24265 |
68371 | L-arabitol | - | builds acid from | 18403 |
68371 | D-arabitol | - | builds acid from | 18333 |
68371 | L-fucose | + | builds acid from | 18287 |
68371 | D-fucose | - | builds acid from | 28847 |
68371 | D-tagatose | - | builds acid from | 16443 |
68371 | D-lyxose | - | builds acid from | 62318 |
68371 | turanose | + | builds acid from | 32528 |
68371 | gentiobiose | - | builds acid from | 28066 |
68371 | xylitol | - | builds acid from | 17151 |
68371 | starch | - | builds acid from | 28017 |
68371 | raffinose | + | builds acid from | 16634 |
68371 | melezitose | - | builds acid from | 6731 |
68371 | trehalose | - | builds acid from | 27082 |
68371 | sucrose | + | builds acid from | 17992 |
68371 | melibiose | + | builds acid from | 28053 |
68371 | lactose | + | builds acid from | 17716 |
68371 | maltose | + | builds acid from | 17306 |
68371 | cellobiose | - | builds acid from | 17057 |
68371 | amygdalin | - | builds acid from | 27613 |
68371 | methyl alpha-D-glucopyranoside | + | builds acid from | 320061 |
68371 | methyl alpha-D-mannoside | - | builds acid from | 43943 |
68371 | D-sorbitol | - | builds acid from | 17924 |
68371 | D-mannitol | - | builds acid from | 16899 |
68371 | myo-inositol | - | builds acid from | 17268 |
68371 | galactitol | - | builds acid from | 16813 |
68371 | L-rhamnose | - | builds acid from | 62345 |
68371 | L-sorbose | - | builds acid from | 17266 |
68371 | D-fructose | + | builds acid from | 15824 |
68371 | D-glucose | + | builds acid from | 17634 |
68371 | D-galactose | + | builds acid from | 12936 |
68371 | methyl beta-D-xylopyranoside | - | builds acid from | 74863 |
68371 | ribitol | - | builds acid from | 15963 |
68371 | L-xylose | - | builds acid from | 65328 |
68371 | D-xylose | - | builds acid from | 65327 |
68371 | D-ribose | + | builds acid from | 16988 |
68371 | L-arabinose | - | builds acid from | 30849 |
68371 | D-arabinose | + | builds acid from | 17108 |
68371 | erythritol | - | builds acid from | 17113 |
68371 | glycerol | - | builds acid from | 17754 |
120651 | esculin | - | hydrolysis | 4853 |
120651 | nitrate | - | reduction | 17632 |
120651 | nitrite | - | reduction | 16301 |
120651 | tributyrin | + | hydrolysis | 35020 |
metabolite production
- @ref: 120651
- Chebi-ID: 35581
- metabolite: indole
- production: no
enzymes
@ref | value | activity | ec |
---|---|---|---|
68382 | alpha-fucosidase | - | 3.2.1.51 |
68382 | alpha-mannosidase | - | 3.2.1.24 |
68382 | N-acetyl-beta-glucosaminidase | + | 3.2.1.52 |
68382 | beta-glucosidase | + | 3.2.1.21 |
68382 | alpha-glucosidase | + | 3.2.1.20 |
68382 | beta-glucuronidase | - | 3.2.1.31 |
68382 | beta-galactosidase | + | 3.2.1.23 |
68382 | alpha-galactosidase | + | 3.2.1.22 |
68382 | naphthol-AS-BI-phosphohydrolase | + | |
68382 | acid phosphatase | + | 3.1.3.2 |
68382 | alpha-chymotrypsin | - | 3.4.21.1 |
68382 | trypsin | - | 3.4.21.4 |
68382 | cystine arylamidase | - | 3.4.11.3 |
68382 | valine arylamidase | - | |
68382 | leucine arylamidase | + | 3.4.11.1 |
68382 | lipase (C 14) | - | |
68382 | esterase lipase (C 8) | + | |
68382 | esterase (C 4) | + | |
68382 | alkaline phosphatase | - | 3.1.3.1 |
120651 | oxidase | - | |
120651 | beta-galactosidase | + | 3.2.1.23 |
120651 | gelatinase | - | |
120651 | amylase | - | |
120651 | DNase | - | |
120651 | caseinase | - | 3.4.21.50 |
120651 | catalase | - | 1.11.1.6 |
120651 | tween esterase | - | |
120651 | lecithinase | - | |
120651 | lipase | - | |
120651 | protease | - | |
120651 | urease | - | 3.5.1.5 |
API zym
@ref | Control | Alkaline phosphatase | Esterase | Esterase Lipase | Lipase | Leucine arylamidase | Valine arylamidase | Cystine arylamidase | Trypsin | alpha- Chymotrypsin | Acid phosphatase | Naphthol-AS-BI-phosphohydrolase | alpha- Galactosidase | beta- Galactosidase | beta- Glucuronidase | alpha- Glucosidase | beta- Glucosidase | N-acetyl-beta- glucosaminidase | alpha- Mannosidase | alpha- Fucosidase |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120651 | - | - | + | + | - | + | - | - | - | - | + | + | + | + | - | + | + | + | - | - |
API 50CHac
@ref | Q | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8514 | - | - | - | + | - | + | - | - | - | - | + | + | + | + | - | - | - | - | - | - | - | + | + | - | + | + | + | - | + | + | + | + | - | +/- | - | + | - | - | - | - | + | - | - | - | + | - | - | - | - | - |
8514 | - | - | - | + | - | + | - | - | - | - | + | + | + | + | - | - | - | - | - | - | - | + | - | - | - | + | + | - | + | + | + | + | - | - | - | + | - | - | - | - | + | - | - | - | + | - | - | - | - | - |
8514 | - | - | - | + | - | + | - | - | - | - | + | + | + | - | - | - | - | - | - | - | - | + | - | - | - | + | - | - | + | + | + | + | - | - | - | + | - | - | - | - | + | - | - | - | + | - | - | - | - | - |
8514 | - | - | - | + | - | + | - | - | - | - | + | + | + | + | - | - | - | - | - | - | - | + | + | - | + | + | + | - | + | + | + | + | - | +/- | - | + | - | - | - | - | + | - | - | - | + | - | - | - | - | - |
8514 | - | - | - | + | - | + | - | - | - | - | + | + | + | + | - | - | - | - | - | - | - | + | + | - | - | + | + | - | + | + | + | + | - | + | - | + | - | + | - | - | + | - | - | - | + | - | - | - | - | - |
8514 | - | - | - | + | - | + | - | - | - | - | + | + | + | + | - | - | - | - | - | - | - | + | + | - | + | +/- | + | - | + | + | + | + | - | + | - | + | - | - | - | - | + | - | - | - | + | - | - | - | - | - |
Isolation, sampling and environmental information
isolation
@ref | sample type |
---|---|
8514 | intestine of infant |
67770 | Intestine of infant |
120651 | Human, Infant, intestine |
isolation source categories
Cat1 | Cat2 | Cat3 |
---|---|---|
#Host | #Human | #Child |
#Host Body-Site | #Gastrointestinal tract |
Safety information
risk assessment
@ref | biosafety level | biosafety level comment |
---|---|---|
8514 | 1 | Risk group (German classification) |
120651 | 1 | Risk group (French classification) |
Sequence information
16S sequences
@ref | description | accession | length | database | NCBI tax ID |
---|---|---|---|---|---|
20218 | Bifidobacterium longum bv. Infantis gene for 16S rRNA, partial sequence, strain: ATCC 15697 | D86184 | 1515 | ena | 391904 |
20218 | Bifidobacterium longum subsp. infantis strain DSM 20088 16S ribosomal RNA gene, partial sequence | HQ012021 | 940 | ena | 391904 |
20218 | Bifidobacterium infantis (ATCC 15697) 16S ribosomal RNA gene, partial | M84783 | 642 | ena | 1682 |
20218 | Bifidobacterium infantis ATCC 15697 16S-23S intergenic spacer, partial sequence | U09792 | 477 | ena | 391904 |
20218 | B.infantis (CIP 6469) DNA sequence for 16S rRNA | X70974 | 1458 | ena | 391904 |
20218 | Bifidobacterium sp. 16S and 23S rRNA genes and ITS | X89111 | 2013 | ena | 391904 |
67770 | Bifidobacterium longum subsp. infantis gene for 16S ribosomal RNA, partial sequence, strain: JCM 1222 | LC071820 | 1452 | ena | 391904 |
67770 | Bifidobacterium infantis 16S ribosomal RNA | M58738 | 1474 | ena | 1682 |
Genome sequences
@ref | description | accession | assembly level | database | NCBI tax ID |
---|---|---|---|---|---|
66792 | Bifidobacterium longum subsp. infantis NCTC11817 | GCA_900637215 | complete | ncbi | 1682 |
66792 | Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 | GCA_000020425 | complete | ncbi | 391904 |
66792 | Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 | GCA_000269965 | complete | ncbi | 391904 |
66792 | Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 | 391904.5 | complete | patric | 391904 |
66792 | Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 | 391904.8 | complete | patric | 391904 |
66792 | Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 | 391904.20 | wgs | patric | 391904 |
66792 | Bifidobacterium longum subsp. infantis strain NCTC11817 | 1682.48 | complete | patric | 1682 |
66792 | Bifidobacterium longum infantis ATCC 15697 | 643348516 | complete | img | 391904 |
66792 | Bifidobacterium longum infantis JCM 1222 | 651053007 | complete | img | 391904 |
66792 | Bifidobacterium longum infantis ATCC 15697 | 2657245662 | draft | img | 391904 |
67770 | Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 | GCA_000771105 | contig | ncbi | 391904 |
GC content
@ref | GC-content | method |
---|---|---|
8514 | 60.8 | |
67770 | 60.8 | thermal denaturation, midpoint method (Tm) |
Genome-based predictions
predictions
trait | prediction | confidence | training_data |
---|---|---|---|
spore-forming | no | 99 | no |
motile | no | 93.78 | no |
flagellated | no | 96.875 | no |
gram-positive | yes | 91.071 | no |
anaerobic | yes | 96.223 | yes |
aerobic | no | 94.556 | no |
halophile | no | 73.4 | no |
spore-forming | no | 96.22 | no |
thermophile | no | 97.097 | yes |
glucose-util | yes | 88.589 | no |
glucose-ferment | yes | 86.418 | no |
External links
@ref: 8514
culture collection no.: DSM 20088, ATCC 15697, NCTC 11817, JCM 1222, BCRC 14602, BCRC 15416, CCM 4990, CCUG 18368, CECT 4551, CGMCC 1.1853, CGMCC 1.2202, CIP 64.67, KCTC 3249, KCTC 3270, LMG 8811, NCFB 2205, NCDO 2205
straininfo link
- @ref: 71390
- straininfo: 7401
literature
topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
---|---|---|---|---|---|---|---|---|
Pathogenicity | 2469742 | Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan. | Ishihara K, Hayasaka K, Yamazaki N | J Invest Dermatol | 10.1111/1523-1747.ep13076752 | 1989 | Biological Factors/administration & dosage/*therapeutic use, Biological Products/administration & dosage/*therapeutic use, Cell Wall Skeleton, Cytokines, DNA, Bacterial/administration & dosage/therapeutic use, Glycine/administration & dosage/analogs & derivatives/therapeutic use, Humans, Interferon Type I/administration & dosage/therapeutic use, Interferon-gamma/administration & dosage/therapeutic use, Interferons/administration & dosage/*therapeutic use, Interleukin-2/administration & dosage/therapeutic use, Leucine/administration & dosage/analogs & derivatives/therapeutic use, Male, Melanoma/*therapy, Middle Aged, Mucoproteins/administration & dosage/therapeutic use, Mycolic Acids/administration & dosage/therapeutic use, Picibanil/administration & dosage/therapeutic use, Recombinant Proteins, Skin Neoplasms/*therapy, Tumor Necrosis Factor-alpha/administration & dosage/therapeutic use | |
Phylogeny | 8550438 | Isolation and structural analysis of polysaccharide containing galactofuranose from the cell walls of Bifidobacterium infantis. | Tone-Shimokawa Y, Toida T, Kawashima T | J Bacteriol | 10.1128/jb.178.1.317-320.1996 | 1996 | Bifidobacterium/*chemistry, Carbohydrate Sequence, Cell Wall/chemistry, Disaccharides/*analysis/chemistry, Galactans/chemistry, Galactose/*analysis/chemistry, Glucosamine/analysis, Glucose/analysis, Molecular Sequence Data, Muramic Acids/analysis, Polysaccharides, Bacterial/chemistry/*isolation & purification | Genetics |
Pathogenicity | 8872711 | Growth characteristics of bifidobacteria in infant formulas. | Dubey UK, Mistry VV | J Dairy Sci | 10.3168/jds.S0022-0302(96)76468-8 | 1996 | Acetic Acid/metabolism, Animals, Bifidobacterium/cytology/*growth & development, Buffers, Caseins, Fats/analysis, Humans, Hydrogen-Ion Concentration, Infant Food/analysis/*microbiology, Infant, Newborn, Kinetics, Lactic Acid/biosynthesis, Milk, Protein Hydrolysates, Proteins/analysis, Soybeans | Enzymology |
Pathogenicity | 8872712 | Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas. | Dubey UK, Mistry VV | J Dairy Sci | 10.3168/jds.S0022-0302(96)76469-X | 1996 | Acetic Acid/metabolism, Bifidobacterium/*drug effects/*growth & development, Caseins, Colony Count, Microbial, Fructose/*pharmacology, Humans, Hydrogen-Ion Concentration, Infant, Infant Food/analysis/*microbiology, Lactic Acid/biosynthesis, Lactulose/*pharmacology, Oligosaccharides/*pharmacology, Protein Hydrolysates, Soybeans | Metabolism |
Metabolism | 9862646 | Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. | Chung KT, Lu Z, Chou MW | Food Chem Toxicol | 10.1016/s0278-6915(98)00086-6 | 1998 | Bacteria/*drug effects/growth & development/isolation & purification, Depression, Chemical, Gallic Acid/analogs & derivatives/metabolism/pharmacology, Humans, Hydrolyzable Tannins/analogs & derivatives/metabolism/*pharmacology, Intestines/*drug effects/microbiology, Iron/metabolism, Microbial Sensitivity Tests, Propyl Gallate/metabolism/pharmacology, Siderophores/metabolism | Pathogenicity |
11028956 | Survival of bifidobacteria in yogurt and simulated gastric juice following immobilization in gellan-xanthan beads. | Sun W, Griffiths MW | Int J Food Microbiol | 10.1016/s0168-1605(00)00327-5 | 2000 | Bifidobacterium/*growth & development, Cells, Immobilized/physiology, Colony Count, Microbial, Food Additives, Gastric Juice/*microbiology, Hydrogen-Ion Concentration, Microspheres, *Polysaccharides, Bacterial, Time Factors, Yogurt/*microbiology | ||
Enzymology | 11319112 | Intra- and extracellular beta-galactosidases from Bifidobacterium bifidum and B. infantis: molecular cloning, heterologous expression, and comparative characterization. | Moller PL, Jorgensen F, Hansen OC, Madsen SM, Stougaard P | Appl Environ Microbiol | 10.1128/AEM.67.5.2276-2283.2001 | 2001 | Amino Acid Sequence, Bifidobacterium/classification/*enzymology/genetics, Binding Sites/genetics, Escherichia coli/enzymology/genetics, Genes, Bacterial, Molecular Sequence Data, Recombinant Proteins/metabolism, Sequence Analysis, DNA, Substrate Specificity, *beta-Galactosidase/chemistry/genetics/isolation & purification/metabolism | Phylogeny |
Metabolism | 11412315 | Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium. | Perrin S, Warchol M, Grill JP, Schneider F | J Appl Microbiol | 10.1046/j.1365-2672.2001.01317.x | 2001 | *Bacterial Proteins, Bacteriological Techniques, Bifidobacterium/*metabolism, Culture Media, Fermentation, Fructose/*metabolism, Glucose/metabolism, Glycoside Hydrolases/metabolism, Oligosaccharides/*metabolism, Sucrose/metabolism | Cultivation |
Metabolism | 12200334 | Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. | Pereira DI, Gibson GR | Appl Environ Microbiol | 10.1128/AEM.68.9.4689-4693.2002 | 2002 | Bifidobacterium/drug effects/growth & development/isolation & purification/*metabolism, Bile/metabolism, Cholesterol/*metabolism, Culture Media, Digestive System/*microbiology, Humans, Hydrochloric Acid/pharmacology, Lactic Acid/metabolism, Lactobacillus/drug effects/growth & development/isolation & purification/*metabolism | Pathogenicity |
Enzymology | 12460425 | Characterization of a purified beta-fructofuranosidase from Bifidobacterium infantis ATCC 15697. | Warchol M, Perrin S, Grill JP, Schneider F | Lett Appl Microbiol | 10.1046/j.1472-765x.2002.01224.x | 2002 | Bifidobacterium/*enzymology/growth & development, Electrophoresis, Polyacrylamide Gel, *Glycoside Hydrolases/chemistry/isolation & purification/metabolism, Hydrogen-Ion Concentration, Kinetics, Temperature, beta-Fructofuranosidase | Phylogeny |
Pathogenicity | 12650667 | Growth inhibition of intestinal bacteria and mutagenicity of 2-, 3-, 4-aminobiphenyls, benzidine, and biphenyl. | Chung KT, Adris P | Toxicol In Vitro | 10.1016/s0887-2333(02)00131-5 | 2003 | Aminobiphenyl Compounds/*toxicity, Benzidines/*toxicity, Biphenyl Compounds/*toxicity, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Humans, Intestines/*microbiology, Mutagenicity Tests, Mutagens/*toxicity | |
Metabolism | 17462768 | Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697. | Haros M, Bielecka M, Honke J, Sanz Y | Int J Food Microbiol | 10.1016/j.ijfoodmicro.2007.02.021 | 2007 | 6-Phytase/metabolism, Bifidobacterium/*enzymology/growth & development/metabolism, *Food Microbiology, Hydrogen-Ion Concentration, Inositol Phosphates/*metabolism, Kinetics, Phytic Acid/metabolism, *Probiotics, Temperature | Enzymology |
Phylogeny | 18398167 | Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov. | Mattarelli P, Bonaparte C, Pot B, Biavati B | Int J Syst Evol Microbiol | 10.1099/ijs.0.65319-0 | 2008 | Bacterial Proteins/genetics, Bacterial Typing Techniques, Bifidobacterium/*classification/*genetics/metabolism, Carbohydrate Metabolism, Chaperonin 60/genetics, DNA, Bacterial/genetics, Fermentation, Genes, Bacterial, Genotype, Nucleic Acid Hybridization, Phenotype, Plasmids/genetics, Polymerase Chain Reaction, RNA, Bacterial/genetics, RNA, Ribosomal, 16S/genetics, Ribotyping, Species Specificity, Terminology as Topic | Metabolism |
Genetics | 19033196 | The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. | Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, Price NP, Richardson PM, Mills DA | Proc Natl Acad Sci U S A | 10.1073/pnas.0809584105 | 2008 | Bacterial Proteins/classification/genetics/metabolism, Bifidobacterium/*genetics/metabolism, Breast Feeding, Female, Gastrointestinal Tract/*microbiology, Genome, Bacterial, Humans, Infant, Newborn, *Milk, Human/chemistry/metabolism, Molecular Sequence Data, Multigene Family, Oligosaccharides/chemistry/metabolism, Phylogeny, Pregnancy | Metabolism |
Metabolism | 20802066 | Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. | LoCascio RG, Desai P, Sela DA, Weimer B, Mills DA | Appl Environ Microbiol | 10.1128/AEM.00675-10 | 2010 | Bifidobacterium/*genetics/metabolism, Comparative Genomic Hybridization, DNA, Bacterial/*genetics, *Genes, Bacterial, Genotype, Humans, Metabolic Networks and Pathways/*genetics, Milk, Human/*metabolism, Molecular Sequence Data, Multigene Family, Multilocus Sequence Typing, Oligosaccharides/*metabolism, Phylogeny, Sequence Analysis, DNA, Urea/metabolism | Genetics |
Metabolism | 21799473 | Substrate promiscuity of N-acetylhexosamine 1-kinases. | Li Y, Yu H, Chen Y, Lau K, Cai L, Cao H, Tiwari VK, Qu J, Thon V, Wang PG, Chen X | Molecules | 10.3390/molecules16086396 | 2011 | *Acetylgalactosamine/analogs & derivatives/metabolism, *Acetylglucosamine/analogs & derivatives/metabolism, Adenosine Triphosphate/metabolism, Amino Acid Sequence, Bifidobacterium/*enzymology/genetics, Carbohydrate Conformation, Cloning, Molecular, Electrophoresis, Capillary, Electrophoresis, Polyacrylamide Gel, Escherichia coli, Galactose/metabolism, Glucose/metabolism, Hydrogen-Ion Concentration, Isoenzymes/genetics/*metabolism, Kinetics, Mannose/metabolism, Molecular Sequence Data, Phosphates/metabolism, Phosphotransferases/genetics/*metabolism, Plasmids, Protein Engineering/*methods, Recombinant Proteins/genetics/*metabolism, Substrate Specificity, Transformation, Bacterial | Enzymology |
Metabolism | 21832085 | Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. | Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka M | J Biol Chem | 10.1074/jbc.M111.248138 | 2011 | Adult, Bifidobacteriales Infections/microbiology, Bifidobacterium/*metabolism, Carbohydrates/chemistry, Chromatography, High Pressure Liquid/methods, Female, Gastrointestinal Tract/microbiology, Humans, Infant, Newborn, Intestines/*microbiology, Japan, Milk, Human/*metabolism, Molecular Sequence Data, Monosaccharides, Oligosaccharides/chemistry/*metabolism, Time Factors | Pathogenicity |
Enzymology | 22138995 | Bifidobacterium longum subsp. infantis ATCC 15697 alpha-fucosidases are active on fucosylated human milk oligosaccharides. | Sela DA, Garrido D, Lerno L, Wu S, Tan K, Eom HJ, Joachimiak A, Lebrilla CB, Mills DA | Appl Environ Microbiol | 10.1128/AEM.06762-11 | 2011 | Bifidobacterium/chemistry/*enzymology/genetics/metabolism, Crystallography, X-Ray, Fermentation, Gene Expression Profiling, Genes, Bacterial, Humans, Kinetics, Milk, Human/*chemistry, Models, Molecular, Multigene Family, Oligosaccharides/*metabolism, Phylogeny, Protein Structure, Tertiary, Sequence Homology, Amino Acid, alpha-L-Fucosidase/chemistry/genetics/*metabolism | Metabolism |
Metabolism | 22579845 | Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. | Garrido D, Ruiz-Moyano S, Mills DA | Anaerobe | 10.1016/j.anaerobe.2012.04.012 | 2012 | Acetylglucosamine/*metabolism, Bifidobacterium/*enzymology/genetics/growth & development, Chromatography, Thin Layer, Cloning, Molecular, Enzyme Activation, Gene Expression Regulation, Bacterial, Gene Expression Regulation, Enzymologic, Genome, Bacterial, Humans, Hydrogen-Ion Concentration, Milk, Human/*chemistry, Oligosaccharides/*metabolism, Substrate Specificity, Uridine Diphosphate N-Acetylglucosamine/metabolism, beta-N-Acetylhexosaminidases/genetics/metabolism | Enzymology |
Metabolism | 22582052 | Novel phytases from Bifidobacterium pseudocatenulatum ATCC 27919 and Bifidobacterium longum subsp. infantis ATCC 15697. | Tamayo-Ramos JA, Sanz-Penella JM, Yebra MJ, Monedero V, Haros M | Appl Environ Microbiol | 10.1128/AEM.00782-12 | 2012 | 6-Phytase/*genetics/metabolism, Bacterial Proteins/genetics/metabolism, Bifidobacterium/*classification/*enzymology/genetics, Humans, Hydrogen-Ion Concentration, Hydrolysis, Phytic Acid/*metabolism, Polymerase Chain Reaction, *Probiotics, Substrate Specificity, Temperature | Pathogenicity |
Enzymology | 22633137 | A highly efficient galactokinase from Bifidobacterium infantis with broad substrate specificity. | Li L, Liu Y, Wang W, Cheng J, Zhao W, Wang P | Carbohydr Res | 10.1016/j.carres.2012.04.022 | 2012 | Bifidobacterium/*enzymology, Galactokinase/isolation & purification/*metabolism, Galactosephosphates/biosynthesis/chemistry/metabolism, Recombinant Proteins/isolation & purification/metabolism, Substrate Specificity | Metabolism |
Pathogenicity | 22897719 | Identification and accurate quantitation of biological oligosaccharide mixtures. | Strum JS, Kim J, Wu S, De Leoz ML, Peacock K, Grimm R, German JB, Mills DA, Lebrilla CB | Anal Chem | 10.1021/ac301128s | 2012 | Bifidobacterium/enzymology, *Chromatography, High Pressure Liquid, Deuterium Exchange Measurement, Gastrointestinal Tract/microbiology, Glycoside Hydrolases/metabolism, Humans, *Mass Spectrometry, Milk, Human/chemistry, Oligosaccharides/*analysis | Enzymology |
Metabolism | 23200660 | Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. | Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom HJ, Block DE, Mills DA | Food Microbiol | 10.1016/j.fm.2012.10.003 | 2012 | Bacterial Proteins/genetics/metabolism, Bifidobacterium/enzymology/genetics/*metabolism, Gastrointestinal Tract/microbiology, Humans, Oligosaccharides/*metabolism, Prebiotics/analysis, beta-Galactosidase/genetics/metabolism | Pathogenicity |
Phylogeny | 23315725 | Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin. | Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao JZ, Abe F, Iwatsuki K | Appl Environ Microbiol | 10.1128/AEM.03343-12 | 2013 | Animals, Bifidobacterium/*drug effects/*growth & development, Cattle, Growth Inhibitors/*isolation & purification/pharmacology, Hydrolysis, Intercellular Signaling Peptides and Proteins/*isolation & purification/pharmacology, Lactoferrin/*metabolism, Microbial Sensitivity Tests, Pepsin A/*metabolism | Enzymology |
Metabolism | 23332852 | Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens. | Chen PW, Jheng TT, Shyu CL, Mao FC | J Dairy Sci | 10.3168/jds.2012-6112 | 2013 | Animals, Anti-Infective Agents/administration & dosage/*therapeutic use, Bifidobacterium/metabolism, Cattle, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Lactobacillus/metabolism, Lactobacillus acidophilus/metabolism, Lactobacillus rhamnosus/metabolism, Lactoferrin/administration & dosage/drug effects/*therapeutic use, Pediococcus/metabolism, Probiotics/administration & dosage/*therapeutic use, Protein Hydrolysates, Salmonella typhimurium/drug effects | Pathogenicity |
Pathogenicity | 23805302 | Exposure of Bifidobacterium longum subsp. infantis to Milk Oligosaccharides Increases Adhesion to Epithelial Cells and Induces a Substantial Transcriptional Response. | Kavanaugh DW, O'Callaghan J, Butto LF, Slattery H, Lane J, Clyne M, Kane M, Joshi L, Hickey RM | PLoS One | 10.1371/journal.pone.0067224 | 2013 | Animals, Bacterial Adhesion/*drug effects/physiology, Bifidobacterium longum subspecies infantis/*metabolism, Caco-2 Cells, Humans, *Intestinal Mucosa/metabolism/microbiology, *Milk, Oligonucleotide Array Sequence Analysis, Oligosaccharides/metabolism/*pharmacokinetics, *Transcription, Genetic | Metabolism |
Enzymology | 24124888 | Enrichment of Bifidobacterium longum subsp. infantis ATCC 15697 within the human gut microbiota using alginate-poly-L-lysine-alginate microencapsulation oral delivery system: an in vitro analysis using a computer-controlled dynamic human gastrointestinal model. | Rodes L, Tomaro-Duchesneau C, Saha S, Paul A, Malhotra M, Marinescu D, Shao W, Kahouli I, Prakash S | J Microencapsul | 10.3109/02652048.2013.834990 | 2013 | Administration, Oral, *Alginates/chemistry/pharmacokinetics/pharmacology, *Bifidobacterium, Capsules, *Computer Simulation, Humans, Intestines/*microbiology, *Microbiota, *Models, Biological, Polylysine/*analogs & derivatives/chemistry/pharmacokinetics/pharmacology, Stomach/*microbiology | Pathogenicity |
Metabolism | 24255712 | Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules. | Miyauchi E, Ogita T, Miyamoto J, Kawamoto S, Morita H, Ohno H, Suzuki T, Tanabe S | PLoS One | 10.1371/journal.pone.0079735 | 2013 | Animals, B7-1 Antigen/genetics/metabolism, B7-2 Antigen/genetics/metabolism, Bifidobacterium/*metabolism, CD40 Antigens/genetics/metabolism, Colitis/chemically induced/genetics/immunology/*metabolism/microbiology, Cytokines/metabolism, Dextran Sulfate/adverse effects, Female, Gene Expression Regulation, Interleukin-17/*metabolism, Intestinal Mucosa/immunology/metabolism/pathology, Mice, Th17 Cells/immunology/metabolism, Transcription Factors/genetics/metabolism | |
Metabolism | 24270321 | Distinct substrate specificities of three glycoside hydrolase family 42 beta-galactosidases from Bifidobacterium longum subsp. infantis ATCC 15697. | Viborg AH, Katayama T, Abou Hachem M, Andersen MC, Nishimoto M, Clausen MH, Urashima T, Svensson B, Kitaoka M | Glycobiology | 10.1093/glycob/cwt104 | 2013 | Amino Acid Sequence, Bifidobacterium/*enzymology/genetics/metabolism, Galactans/metabolism, Galactose/metabolism, Galactosides/metabolism, Glycoside Hydrolases/chemistry/genetics/*metabolism, Models, Molecular, Molecular Sequence Data, Multigene Family, Phylogeny, Substrate Specificity, beta-Galactosidase/chemistry/genetics/*metabolism | Genetics |
Pathogenicity | 24967382 | Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. | Rodes L, Saha S, Tomaro-Duchesneau C, Prakash S | Biomed Res Int | 10.1155/2014/602832 | 2014 | Animals, *Bifidobacterium, Colon/*metabolism/*microbiology, Endotoxemia/blood/microbiology/therapy, Endotoxins/*blood, Humans, Male, *Microbiota, Rats, Rats, Inbred F344 | Metabolism |
Metabolism | 25435500 | Multi-functional glycoside hydrolase: Blon_0625 from Bifidobacterium longum subsp. infantis ATCC 15697. | Matsumoto T, Shimada S, Hata Y, Tanaka T, Kondo A | Enzyme Microb Technol | 10.1016/j.enzmictec.2014.10.001 | 2014 | Actinobacteria/enzymology/genetics, Alteromonadaceae/enzymology/genetics, Bacterial Proteins/genetics/*isolation & purification/metabolism, Bifidobacterium/*enzymology/genetics, Biodegradation, Environmental, Cellobiose/metabolism, Disaccharides/metabolism, Gene Expression Regulation, Bacterial, Genes, Bacterial, Glycoside Hydrolases/genetics/*isolation & purification/metabolism, Hydrolysis, Lignin/metabolism, Oligosaccharides/metabolism, Recombinant Fusion Proteins/metabolism, Substrate Specificity | Enzymology |
Pathogenicity | 25794720 | Enzymatic production of HMO mimics by the sialylation of galacto-oligosaccharides. | Wang Y, Jiang K, Ma H, Zeng W, Wang PG, Yao N, Han W, Cheng J, Wang W | Food Chem | 10.1016/j.foodchem.2015.02.064 | 2015 | Health Maintenance Organizations, Humans, Milk, Human, Oligosaccharides/*chemistry, Polysaccharides/*chemistry, Prebiotics | Biotechnology |
Enzymology | 25942062 | Comparing substrate specificity of two UDP-sugar pyrophosphorylases and efficient one-pot enzymatic synthesis of UDP-GlcA and UDP-GalA. | Guo Y, Fang J, Li T, Li X, Ma C, Wang X, Wang PG, Li L | Carbohydr Res | 10.1016/j.carres.2015.04.001 | 2015 | Arabidopsis/enzymology, Arabidopsis Proteins/*chemistry, Bacterial Proteins/*chemistry, Bifidobacterium/enzymology, Biocatalysis, Kinetics, Nucleotidyltransferases/*chemistry, Substrate Specificity, Uridine Diphosphate Glucuronic Acid/*chemistry, Uridine Diphosphate Sugars/*chemistry | |
Stress | 26097235 | Characterizing the release of bioactive N-glycans from dairy products by a novel endo-beta-N-acetylglucosaminidase. | Karav S, Bell JM, Le Parc A, Liu Y, Mills DA, Block DE, Barile D | Biotechnol Prog | 10.1002/btpr.2135 | 2015 | Animals, Bifidobacterium/*enzymology, Cattle, Colostrum/chemistry, Dairy Products/*analysis, Glycoproteins/chemistry, Hot Temperature, Hydrogen-Ion Concentration, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/*metabolism, Polysaccharides/*chemistry | Enzymology |
Enzymology | 26101185 | A novel endo-beta-N-acetylglucosaminidase releases specific N-glycans depending on different reaction conditions. | Parc AL, Karav S, De Moura Bell JMLN, Frese SA, Liu Y, Mills DA, Block DE, Barile D | Biotechnol Prog | 10.1002/btpr.2133 | 2015 | Animals, Bifidobacterium/enzymology, Cattle, Chemical Phenomena, Colostrum, Glycoproteins/chemistry, Glycosylation, Hydrogen-Ion Concentration, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/*metabolism, Milk Proteins/chemistry, Pilot Projects, Polysaccharides/*chemistry, Temperature | Metabolism |
Enzymology | 26210151 | Functional analysis of the type II toxin-antitoxin systems of the MazEF and RelBE families in Bifidobacterium longum subsp. infantis ATCC 15697. | Averina O, Alekseeva M, Shkoporov A, Danilenko V | Anaerobe | 10.1016/j.anaerobe.2015.07.007 | 2015 | Bacterial Toxins/*genetics, Bifidobacterium/*genetics/growth & development, Cloning, Molecular, Escherichia coli/genetics/physiology, Gene Expression Profiling, Microbial Viability, *Operon | Pathogenicity |
Metabolism | 26337101 | Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria. | Garrido D, Ruiz-Moyano S, Lemay DG, Sela DA, German JB, Mills DA | Sci Rep | 10.1038/srep13517 | 2015 | Animals, Bifidobacterium/*metabolism, Gastrointestinal Microbiome/physiology, Humans, Intestinal Mucosa/*metabolism, Intestines/*microbiology, Milk, Human/*chemistry/microbiology, Oligosaccharides/*metabolism, Transcription Factors/*metabolism, Transcriptome/physiology | Pathogenicity |
Pathogenicity | 26689225 | Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response. | Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, Leenen PJ | Benef Microbes | 10.3920/BM2015.0094 | 2015 | Age Factors, Aging/drug effects/*immunology, Animals, Bifidobacterium/*physiology, Humans, Interleukin-10/immunology, Interleukin-6/immunology, Lactobacillus/*physiology, Macrophages/drug effects/*immunology, Male, Mice, Mice, Inbred C57BL, Probiotics/*pharmacology, Spleen/cytology/drug effects/*immunology, Tumor Necrosis Factor-alpha/immunology | |
Phylogeny | 26823373 | Bifidobacterium eulemuris sp. nov., isolated from faeces of black lemurs (Eulemur macaco). | Michelini S, Modesto M, Pisi AM, Filippini G, Sandri C, Spiezio C, Biavati B, Sgorbati B, Mattarelli P | Int J Syst Evol Microbiol | 10.1099/ijsem.0.000924 | 2016 | ||
Metabolism | 26859770 | Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach. | Turroni F, Milani C, Duranti S, Mancabelli L, Mangifesta M, Viappiani A, Lugli GA, Ferrario C, Gioiosa L, Ferrarini A, Li J, Palanza P, Delledonne M, van Sinderen D, Ventura M | ISME J | 10.1038/ismej.2015.236 | 2016 | Bifidobacterium/*metabolism/physiology, Carbohydrate Metabolism, Fatty Acids, Volatile/metabolism, *Gastrointestinal Microbiome, Humans, Intestines/microbiology, Polysaccharides/metabolism, Starch/metabolism | Pathogenicity |
Metabolism | 27084007 | Oligosaccharides Released from Milk Glycoproteins Are Selective Growth Substrates for Infant-Associated Bifidobacteria. | Karav S, Le Parc A, Leite Nobrega de Moura Bell JM, Frese SA, Kirmiz N, Block DE, Barile D, Mills DA | Appl Environ Microbiol | 10.1128/AEM.00547-16 | 2016 | Animals, Bifidobacterium/*enzymology/growth & development/*metabolism, Glycoproteins/*metabolism, Humans, Infant, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/*metabolism, Milk/*metabolism, Oligosaccharides/*metabolism | Pathogenicity |
Metabolism | 27086652 | Functional characterization of a novel beta-fructofuranosidase from Bifidobacterium longum subsp. infantis ATCC 15697 on structurally diverse fructans. | Avila-Fernandez A, Cuevas-Juarez E, Rodriguez-Alegria ME, Olvera C, Lopez-Munguia A | J Appl Microbiol | 10.1111/jam.13154 | 2016 | Bacterial Proteins/chemistry/genetics/*metabolism, Bifidobacterium longum subspecies infantis/*enzymology/genetics/metabolism, Fructans/*chemistry/*metabolism, Molecular Weight, Oligosaccharides/chemistry/metabolism, Substrate Specificity, Sucrose/metabolism, beta-Fructofuranosidase/chemistry/genetics/*metabolism | Enzymology |
Enzymology | 27718339 | Recent advances in immobilization strategies for glycosidases. | Karav S, Cohen JL, Barile D, de Moura Bell JM | Biotechnol Prog | 10.1002/btpr.2385 | 2016 | Bifidobacterium longum/enzymology, Enzymes, Immobilized/*chemistry, Glycoside Hydrolases/*chemistry/metabolism, Glycosylation, Mannose/chemistry, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/*chemistry/metabolism, Polysaccharides/*chemistry, Protein Folding | Metabolism |
Metabolism | 28780103 | Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. | Thongaram T, Hoeflinger JL, Chow J, Miller MJ | J Dairy Sci | 10.3168/jds.2017-12753 | 2017 | Animals, Bifidobacterium/*metabolism, Humans, Lactobacillus/*metabolism, Milk, Human/*chemistry, Oligosaccharides/*metabolism, Probiotics/metabolism | Pathogenicity |
Biotechnology | 30018849 | Use of design of experiments to optimize the production of microbial probiotic biofilms. | Speranza B, Liso A, Corbo MR | PeerJ | 10.7717/peerj.4826 | 2018 | ||
30513877 | Mining Milk for Factors which Increase the Adherence of Bifidobacterium longum subsp. infantis to Intestinal Cells. | Quinn EM, Slattery H, Thompson AP, Kilcoyne M, Joshi L, Hickey RM | Foods | 10.3390/foods7120196 | 2018 | |||
Genetics | 30927646 | Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients. | Rong H, Xie XH, Zhao J, Lai WT, Wang MB, Xu D, Liu YH, Guo YY, Xu SX, Deng WF, Yang QF, Xiao L, Zhang YL, He FS, Wang S, Liu TB | J Psychiatr Res | 10.1016/j.jpsychires.2019.03.017 | 2019 | Adult, Bipolar Disorder/*microbiology, Depressive Disorder, Major/*microbiology, Feces/microbiology, Female, Gastrointestinal Microbiome/*physiology, Humans, Male, Metagenomics/*methods/statistics & numerical data | Pathogenicity |
Metabolism | 31747272 | Structural Identity of Galactooligosaccharide Molecules Selectively Utilized by Single Cultures of Probiotic Bacterial Strains. | Boger M, van Leeuwen SS, Lammerts van Bueren A, Dijkhuizen L | J Agric Food Chem | 10.1021/acs.jafc.9b05968 | 2019 | Bifidobacterium/growth & development/*metabolism, Lactobacillus/growth & development/*metabolism, Lactobacillus acidophilus/growth & development/metabolism, Oligosaccharides/*chemistry/*metabolism, Prebiotics/analysis, Probiotics/metabolism | |
32192119 | Bifidobacterium longum subsp. infantis ATCC 15697 and Goat Milk Oligosaccharides Show Synergism In Vitro as Anti-Infectives against Campylobacter jejuni. | Quinn EM, Slattery H, Walsh D, Joshi L, Hickey RM | Foods | 10.3390/foods9030348 | 2020 | |||
Pathogenicity | 32610704 | A Whey Fraction Rich in Immunoglobulin G Combined with Bifidobacterium longum subsp. infantis ATCC 15697 Exhibits Synergistic Effects against Campylobacter jejuni. | Quinn EM, Kilcoyne M, Walsh D, Joshi L, Hickey RM | Int J Mol Sci | 10.3390/ijms21134632 | 2020 | Bifidobacterium/growth & development, Bifidobacterium longum subspecies infantis/*drug effects/genetics/metabolism, Campylobacter jejuni/*drug effects/genetics, DNA, Bacterial/genetics, HT29 Cells, Humans, Immunoglobulin G/metabolism, Intestines/microbiology, Microbiota/genetics, Whey/*chemistry/metabolism, Whey Proteins/metabolism/*pharmacology | Metabolism |
Metabolism | 32985563 | Strain-specific strategies of 2'-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697. | Zabel BE, Gerdes S, Evans KC, Nedveck D, Singles SK, Volk B, Budinoff C | Sci Rep | 10.1038/s41598-020-72792-z | 2020 | Bifidobacterium longum/*metabolism, Gastrointestinal Tract/*microbiology, Humans, Infant, Oligosaccharides/*metabolism, Species Specificity, Trisaccharides/*metabolism | Pathogenicity |
Biotechnology | 33042083 | Riboflavin Biosynthesis and Overproduction by a Derivative of the Human Gut Commensal Bifidobacterium longum subsp. infantis ATCC 15697. | Solopova A, Bottacini F, Venturi Degli Esposti E, Amaretti A, Raimondi S, Rossi M, van Sinderen D | Front Microbiol | 10.3389/fmicb.2020.573335 | 2020 | ||
Phylogeny | 33226935 | Five novel bifidobacterial species isolated from faeces of primates in two Czech zoos: Bifidobacterium erythrocebi sp. nov., Bifidobacterium moraviense sp. nov., Bifidobacterium oedipodis sp. nov., Bifidobacterium olomucense sp. nov. and Bifidobacterium panos sp. nov. | Neuzil-Bunesova V, Lugli GA, Modrackova N, Vlkova E, Bolechova P, Burtscher J, Longhi G, Mancabelli L, Killer J, Domig K, Ventura M | Int J Syst Evol Microbiol | 10.1099/ijsem.0.004573 | 2020 | Animals, Animals, Zoo/microbiology, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/isolation & purification, Czech Republic, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/*microbiology, Nucleic Acid Hybridization, *Phylogeny, Primates/*microbiology, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNA | Transcriptome |
Metabolism | 33460787 | Generating a fucose permease deletion mutant in Bifidobacterium longum subspecies infantis ATCC 15697. | Higgins MA, Ryan KS | Anaerobe | 10.1016/j.anaerobe.2021.102320 | 2021 | Bacterial Proteins/*genetics/metabolism, Bifidobacterium longum subspecies infantis/*enzymology/genetics/metabolism, Fucose/*metabolism, Gene Deletion, Membrane Transport Proteins/*genetics/metabolism | Enzymology |
33579683 | A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in pure culture and in human fermented faecal communities. | Warda AK, Clooney AG, Ryan F, de Almeida Bettio PH, Di Benedetto G, Ross RP, Hill C | Appl Environ Microbiol | 10.1128/AEM.02459-20 | 2021 | |||
Metabolism | 34429696 | 1,6-alpha-L-Fucosidases from Bifidobacterium longum subsp. infantis ATCC 15697 Involved in the Degradation of Core-fucosylated N -Glycan. | Ashida H, Fujimoto T, Kurihara S, Nakamura M, Komeno M, Huang Y, Katayama T, Kinoshita T, Takegawa K | J Appl Glycosci (1999) | 10.5458/jag.jag.JAG-2019_0016 | 2020 | ||
Pathogenicity | 34553672 | Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile. | Hirano R, Sakanaka M, Yoshimi K, Sugimoto N, Eguchi S, Yamauchi Y, Nara M, Maeda S, Ami Y, Gotoh A, Katayama T, Iida N, Kato T, Ohno H, Fukiya S, Yokota A, Nishimoto M, Kitaoka M, Nakai H, Kurihara S | Gut Microbes | 10.1080/19490976.2021.1973835 | 2021 | ATP-Binding Cassette Transporters/metabolism, Animals, Bifidobacterium/genetics/*growth & development, Bifidobacterium longum subspecies infantis/genetics/*growth & development, Clostridioides difficile/*growth & development, Disaccharides/*pharmacology, Gastrointestinal Microbiome/drug effects, Humans, Intestines/microbiology, Male, Mice, Mice, Inbred C57BL, Prebiotics/*analysis | Metabolism |
Phylogeny | 35208658 | Phylogenetic, Functional and Safety Features of 1950s B. infantis Strains. | Duboux S, Ngom-Bru C, De Bruyn F, Bogicevic B | Microorganisms | 10.3390/microorganisms10020203 | 2022 | ||
Pathogenicity | 35219990 | The mechanism of probiotic action of human milk N-glycome towards B. infantis ATCC 15697 and identification of the principal functional components. | Mao H, Li S, Yin B, Lin X, Guo J, Wang T, Voglmeir J, Liu L | Food Chem | 10.1016/j.foodchem.2022.132532 | 2022 | Bifidobacterium longum subspecies infantis, Humans, *Milk, Human, Oligosaccharides, Polysaccharides, *Probiotics | |
Metabolism | 36252443 | Release of bifidogenic N-glycans from native bovine colostrum proteins by an endo-beta-N-acetylglucosaminidase. | Bunyatratchata A, Parc AL, de Moura Bell JMLN, Cohen JL, Duman H, Arslan A, Kaplan M, Barile D, Karav S | Enzyme Microb Technol | 10.1016/j.enzmictec.2022.110138 | 2022 | Humans, Pregnancy, Female, *Acetylglucosaminidase/analysis, *Colostrum/chemistry/metabolism, Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase/analysis, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/analysis/chemistry/metabolism, Polysaccharides/metabolism, Glycoproteins/metabolism | Pathogenicity |
Reference
@id | authors | catalogue | doi/url | title | journal | pubmed |
---|---|---|---|---|---|---|
8514 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20088) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-20088 | |||
20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |||
20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P. | 10.1016/j.syapm.2013.11.002 | StrainInfo introduces electronic passports for microorganisms. | Syst Appl Microbiol. 37: 42-50 2014 | 24321274 | |
37702 | Curators of the CIP | https://brclims.pasteur.fr/brcWeb/souche/detail/1/10172 | ||||
66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
67770 | Curators of the JCM | https://jcm.brc.riken.jp/en/ | ||||
68371 | Automatically annotated from API 50CH acid | |||||
68382 | Automatically annotated from API zym | |||||
69480 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
69481 | Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch | 10.21203/rs.3.rs-2527258/v1 | Predictions based on the model GenomeNet Sporulation v. 1 | |||
71390 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID7401.1 | StrainInfo: A central database for resolving microbial strain identifiers | |||
120651 | Curators of the CIP | Collection of Institut Pasteur (CIP 64.67) | https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2064.67 |